TriSalus Reports Q2 2024 Financial Results and Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Wall Street sinks as bond yields rise, Walmart results disappoint
Jones Trading Reiterates Buy Rating on TriSalus Life Sciences, Inc. (TLSI)
August 16, 2024 2:54 PM EDTJones Trading analyst Justin Walsh reiterated a Buy rating and $11.00 price target on TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
The analyst comments "Nelitolimod delivered with the TriNav system will provide clinical benefit to patients with amenable solid tumors. TriNav will continue... More
